Grantham, Mayo, Van Otterloo & Co (GMO)’s UBS Group UBS Stock Holding History
Bought
Maintained
Sold
Other funds holding UBS
CCI
Grantham, Mayo, Van Otterloo & Co (GMO)'s UBS Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its UBS Group (UBS) stake by 145% in Q2 2026, buying an estimated $35.3M and bringing the position to 1,308,707 shares worth $65M. The position accounts for 0.15% of the portfolio, ranked #55.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in UBS in Q3 2016 and has held it in 22 quarters since. The position peaked at $108M in Q4 2022. 765 funds tracked by Wall St. Rank hold UBS as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 1,308,707 shares of UBS Group worth $65M as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 775,073 UBS Group shares in Q2 2026, an estimated $35.3M.
- UBS Group made up 0.15% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #55 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in UBS Group in Q3 2016 and has held it in 22 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s UBS Group position peaked at $108M in Q4 2022.
- 765 funds tracked by Wall St. Rank held UBS Group as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.